Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase

Neuroscience

Volumn 86, Issue 2, 1998, Pages 511-519

  Watts, P M ^a   Riedl, A G ^a   Douek, D C ^b   Edwards, R J ^b   Boobis, A R ^b   Jenner, P ^a   Marsden, C D ^c  

^a Biomedical Sciences Division   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Confocal microscopy; CYP2C13 2C6; CYP2E1; Cytochrome P450; Immunohistochemistry; Parkinson's disease

Indexed keywords

ANTISERUM; CYTOCHROME P450; DOPAMINE; FREE RADICAL; GLIAL FIBRILLARY ACIDIC PROTEIN; ISONIAZID; OXIDOREDUCTASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0032101152     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00649-0     Document Type: Article

References (65)

1. Abou-Donia M., Hu Z., Lapadula D. M., Gupta R. P. Mechanisms of joint neurotoxicity of n-hexane, methyl isobutylketone and O-ethyl-O-4-nitrophenyl phenylphosphophonothioate in hens. J. Pharmac. exp. Ther. 257:1991;282-289.
2. Akhmedova S. N., Pushnova E. A., Yakimovsky A. F., Avtonomov V. V., Schwartz E. I. Frequency of a specific cytochrome P4502D6B (CYP2D6B) mutant allele in clinically differentiated groups of patients with Parkinson's disease. Biochem. molec. Med. 54:1995;88-90.
3. Alkayed N. J., Narayanan J., Gebremedhin D., Medhora M., Roman R. J., Harder D. R. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke. 27:1996;971-979.
4. Anandatheerthavarada H. K., Boyd M. R., Ravindranath V. Characterization of a phenobarbital-inducible cytochrome P-450, NADPH-cytochrome P-450 reductase and reconstituted cytochrome P-450 mono-oxygenase system from rat brain: evidence for constitutive presence in rat and human brain. Biochem. J. 288:1992;483-488.
5. Anandatheerthavarada H. K., Shankar S. K., Bhamre S., Boyd M. R., Song B. J., Ravindranath V. Induction of brain cytochrome P-450IIE1 by chronic ethanol treatment. Brain Res. 601:1993;279-285.
6. Anandatheerthavarada H. K., Shankar S. K., Ravindranath V. Rat brain cytochromes P-450: catalytic, immunochemical properties and inducibility of multiple forms. Brain Res. 536:1990;339-343.
7. Anandatheerthavarada H. K., Williams J. F., Wecker L. The chronic administration of nicotine induces cytochrome P-450 in rat brain. J. Neurochem. 60:1993;1941-1944.
8. Anandatheerthavarada H. K., Williams J. F., Wecker L. Differential effect of chronic nicotine administration on brain cytochrome P4501A1/2 and P4502E1. Biochem. biophys. Res. Commun. 194:1993;312-318.
9. Armstrong M., Daly A. K., Cholerton S., Bateman D. N., Idle J. R. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet. 339:1992;1017-1018.
10. Bhagwat S. V., Boyd M. R., Ravindranath V. Brain mitochondrial cytochromes P450: xenobiotic metabolism, presence of multiple forms and their selective inducibility. Archs Biochem. Biophys. 320:1995;73-83.
11. Bhamre S., Bhagwat S. V., Shankar S. K., Williams D. E., Ravindranath V. Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization. J. Pharmac. exp. Ther. 267:1993;555-559.
12. Bixo M., Backstrom T., Winblad B., Andersson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J. Steroid Biochem. molec. Biol. 55:1995;297-303.
13. Bootman M. A., Phillips I. R. and Shephard E. A. (1996) Flavin-containing monooxygenase expression in the human brain. XIth International Symposium on Microsomes and Drug Oxidations. p. 23.
14. Brittebo E. B. Metabolic activation of the food mutagen Trp-P-1 in endothelial cells of heart and kidney in cytochrome P450-induced mice. Carcinogenesis. 15:1994;667-672.
15. Cammer W., Downing M., Clarke W., Schenkman J. B. Immunocytochemical staining of the RLM6 form of cytochrome P-450 in oligodendrocytes and myelin of rat brain. J. Histochem. Cytochem. 39:1991;1089-1094.
16. Chiodo L. A., Caggiula A. R. Substantia nigra dopamine neurons: alterations in basal discharge rates and autoreceptor sensitivity induced by estrogen. Neuropharmacology. 22:1983;593-599.
17. Coleman T., Ellis S. W., Martin I. J., Lennard M. S., Tucker G. T. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4-implications for susceptibility to Parkinson's disease. J. Pharmac. exp. Ther. 277:1996;685-690.
18. Daly A. K., Cholerton S., Armstrong M., Idle J. R. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ. Health Perspect. 102:1994;55-61.
19. Debri K., Boobis A. R., Davies D. S., Edwards R. J. Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extra-hepatic tissues. Biochem. Pharmac. 50:1995;2047-2056.
20. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P., Marsden C. D. Increased levels of lipid hydroperoxides in the Parkinsonian substantia nigra: an HPLC and ESR study. Movement Disorders. 9:1994;92-97.
21. Dluzen D. E. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice. Brain Res. 715:1996;113-118.
22. Edwards R. J., Murray B. P., Boobis A. R. Anti-peptide antibodies in studies of cytochromes P450 IA. Meth. Enzym. 206:1991;220-233.
23. Edwards R. J., Murray B. P., Singleton A. M., Murray S., Davies D. S., Boobis A. R. Identification of the epitope of an anti-peptide antibody which binds to CYP1A2 in many species including man. Biochem. Pharmac. 46:1993;213-220.
24. Edwards R. J., Singleton A. M., Murray B. P., Davies D. S., Boobis A. R. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes. Biochem. Pharmac. 49:1995;39-47.
25. Farin F. M., Omiecinski C. J. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J. Toxicol. environ. Health. 40:1993;317-335.
26. Gilham D. E., Cairns W., Paine M. J. I., Modi S., Poulsom R., Roberts G. C. K., Wolf C. R. Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization. Xenobiotica. 27:1997;111-125.
27. Hagihara K., Shiosaka S., Lee Y., Kato J., Hatano O., Takakusu A., Emi Y., Omura T., Tohyama M. Presence of sex difference of cytochrome P-450 in rat preoptic area and hypothalamus with reference to coexistence with oxytocin. Brain Res. 515:1990;69-78.
28. Haglund L., Kohler C., Haaparanta T., Goldstein M., Gustafsson J. A. Presence of NADPH-cytochrome P450 reductase in central catecholaminergic neurones. Nature. 307:1984;259-262.
29. Hansson T., Tindberg N., Ingelman-Sundberg M., Kohler C. Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system. Neuroscience. 34:1990;451-463.
30. Hedlund E., Wyss A., Kainu T., Backlund M., Kohler C., Pelto-Huikko M., Gustafsson J. A., Warner M. Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene. Molec. Pharmac. 50:1996;342-350.
31. Jenner P., Dexter D. T., Sian J., Schapira A. H. V., Marsden C. D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy Body disease. Ann. Neurol. 32:1992;S82-S87.
32. Kapitulnik J., Gelboin H. V., Guengerich F. P., Jacobowitz D. M. Immunohistochemical localization of cytochrome P-450 in rat brain. Neuroscience. 20:1987;829-833.
33. Kempermann G., Knoth R., Gebicke-Haerter P. J., Stolz B. J., Volk B. Cytochrome P450 in rat astrocytes in vivo and in vitro: intracellular localization and induction by phenytoin. J. Neurosci. Res. 39:1994;576-588.
34. Kennedy N. P., Tipton K. F. Ethanol metabolism and alcoholic liver disease. Essays Biochem. 25:1990;137-195.
35. Kohler C., Eriksson L. G., Hansson T., Warner M., Gustafsson J. A. Immunohistochemical localization of cytochrome P-450 in the rat brain. Neurosci. Lett. 84:1988;109-114.
36. Kurth M. C., Kurth J. H. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. Am. J. med. Genetics. 48:1993;166-168.
37. Montoliu C., Sancho-Tello M., Azorin I., Burgal M., Valles S., Renau-Piqueras J., Guerri C. Ethanol increases cytochrome P4502E1 and induces oxidative stress in astrocytes. J. Neurochem. 65:1995;2561-2570.
38. Naslund B. M. A., Glaumann H., Warner M., Gustafsson J. A., Hansson T. Cytochrome P-450 b and c in the rat brain and pituitary gland. Molec. Pharmac. 33:1988;31-37.
39. Norris P. J., Hardwick J. P., Emson P. C. Localization of NADPH cytochrome P450 oxidoreductase in rat brain by immunohistochemistry and in situ hybridization and a comparison with the distribution of neuronal NADPH-diaphorase staining. Neuroscience. 61:1994;331-350.
40. Norris P. J., Hardwick J. P., Emson P. C. Regional distribution of cytochrome P450 2D1 in the rat central nervous system. J. comp. Neurol. 366:1996;244-258.
41. Ohta S., Kohno M., Makino Y., Tachikawa O., Hirobe M. Tetrahydroisoquinoline and 1-methyltetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease. Biomed. Res. 8:1987;453-456.
42. Overby L. H., Nishio S., Weir A., Carver G. T., Plopper C. G., Philpot R. M. Distribution of cytochrome P450 1A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: ultrastructural immunolocalization and in situ hybridization. Molec. Pharmac. 41:1992;1039-1046.
43. Park K. S., Sohn D. H., Veech R. L., Song B. J. Translational activation of ethanol-inducible cytochrome P450 (CYP2E1) by isoniazid. Eur. J. Pharmac. 248:1993;7-14.
44. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. 2nd edn. Academic, London.
45. Pezzoli G., Antonini A., Barbieri S., Canesi M., Perbellini L., Zecchinelli A., Mariani C. B., Bonetti A., Leenders K. L. n-hexane induced parkinsonism: pathogenic hypotheses. Movement Disorders. 10:1995;279-282.
46. Pfaff D. W. and Schwartz-Giblin S. (1988). Cellular mechanisms of female reproductive behaviour. In The Physiology of Reproduction. pp. 1487-1568, Raven, New York.
47. Ravindranath V., Anandatheerthavarada H. K., Shankar S. K. NADPH cytochrome P-450 reductase in rat, mouse and human brain. Biochem. Pharmac. 39:1990;1013-1018.
48. Riedl A. G., Watts P. M., Edwards R. J., Boobis A. R., Jenner P., Marsden C. D. Selective localization of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera. Brain Res. 743:1996;324-328.
49. Sasame H. A., Ames M. M., Nelson S. D. Cytochrome P450 and NADPH cytochrome c reductase in rat brain formation of reactive catechol metabolites. Biochem. biophys. Res. Commun. 78:1977;919-926.
50. Schenkman J. B. Steroid metabolism by constitutive cytochromes P450. J. Steroid Biochem. molec. Biol. 43:1992;1023-1030.
51. Schulz T. G., Stahlmann R., Edwards R. J., Debri K., Davies D. S., Neubert D. Enoxacin is an inducer of CYP1A2 in rat liver. Biochem. Pharmac. 50:1995;1517-1520.
52. Segura-Aguilar J. Peroxidase activity of liver microsomal vitamin D 25-hydroxylase and cytochrome P4501A2 catalyses 25-hydroxylation of vitamin D3 and oxidation of dopamine to aminochrome. Biochem. molec. Med. 58:1996;122-129.
53. Smith C. A. D., Gough A. C., Leigh P. N., Summers B. A., Harding A. E., Maranganore D. M., Sturman S. G., Schapira A. H. V., Williams A. C., Spurr N. K., Wolf C. R. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet. 339:1992;1375-1377.
54. Sohda T., Shimizu M., Kamimura S., Okumura M. Immunohistochemical demonstration of ethanol-inducible P450 2E1 in rat brain. Alcohol Alcohol. 28:1993;69-75.
55. Stromstedt M., Warner M., Gustafsson J. A. Cytochrome P450s of the 4A subfamily in the brain. J. Neurochem. 63:1994;671-676.
56. Takakubo F., Yamamoto M., Ogawa N., Yamashita Y., Mizuno Y., Kondon I. Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease. J. neural Transm. 103:1996;843-849.
57. Tanner C. M. The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci. 12:1989;49-54.
58. Tindberg N., Ingelman-Sundberg M. Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system. J. Neurochem. 67:1996;2066-2073.
59. Tsuneoka Y., Matsuo Y., Iwahashi K., Takeuchi H., Ichikawa Y. A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease. J. Biochem. 114:1993;263-266.
60. Tyndale R. F., Sunahara R., Inaba T., Kalow W., Gonzalez F. J., Niznik H. B. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)cocaine and nucleotide sequence identity to human hepatic P450 gene CYP 2D6. Molec. Pharmac. 40:1991;63-68.
61. Warner M., Gustafsson J. A. Effect of ethanol on cytochrome P450 in the rat brain. Proc. natn. Acad. Sci. U.S.A. 91:1994;1019-1023.
62. Warner M., Kohler C., Hansson T., Gustafsson J. A. Regional distribution of cytochrome P-450 in the rat brain: spectral quantitation and contribution of P-450b,e and P-450c,d. J. Neurochem. 50:1988;1057-1065.
63. Wyss A., Gustafsson J. A., Warner M. Cytochromes P450 of the 2D subfamily in rat brain. Molec. Pharmac. 47:1995;1148-1155.
64. Yamada-Mouri N., Hirata S., Hayashi M., Kato J. Analysis of the expression and the first exon of aromatase mRNA in monkey brain. J. Steroid Biochem. molec. Biol. 55:1995;17-23.
65. Yoo M., Ryu H. M., Shin S. W., Yun C. H., Lee S. C., Ji Y. M., You K. H. Identification of cytochrome P450 2E1 in rat brain. Biochem. biophys. Res. Commun. 231:1997;254-256.